Inventors list
Assignees list
Classification tree browser
Top 100 Inventors
Top 100 Assignees
01st week of 2021 patent applcation highlights part 9
Patent application number
Title
Published
20210000809
PROCESS FOR THE PREPARATION OF ABAMETAPIR AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS
2021-01-07
20210000810
PHARMACEUTICAL COMBINATION COMPRISING LSZ102 AND ALPELISIB
2021-01-07
20210000811
3-(HYDROXY)-PYRIDIN-4(1H)-ONE COMPOUNDS AND METHODS OF MAKING AND USING THE SAME
2021-01-07
20210000812
Anti-Androgens For The Treatment Of Non-Metastatic Castrate-Resistant Prostate Cancer
2021-01-07
20210000813
COMPOSITIONS AND METHODS FOR INDUCING CONFORMATIONAL CHANGES IN CEREBLON AND OTHER E3 UBIQUITIN LIGASES
2021-01-07
20210000814
RIMEGEPANT FOR CGRP RELATED DISORDERS
2021-01-07
20210000815
PHARMACOKINETIC ENHANCEMENT OF EZH2 INHIBITORS THROUGH COMBINATION THERAPIES
2021-01-07
20210000816
USE OF CCR5 ANTAGONISTS ALONE OR IN COMBINATION THERAPY FOR THE TREATMENT OF CANCER
2021-01-07
20210000817
TABLETED MEDICINAL COMPOSITION COMPRISING NALFURAFINE
2021-01-07
20210000818
METHODS FOR TREATING DEPRESSIVE SYMPTOMS
2021-01-07
20210000820
BUPROPION AS A MODULATOR OF DRUG ACTIVITY
2021-01-07
20210000821
USE OF FATTY ACID OXIDATION INHIBITORS AS ANTIMICROBIALS
2021-01-07
20210000822
NOVEL METHODS
2021-01-07
20210000823
METHODS OF TREATING HIV
2021-01-07
20210000824
INTERMITTENT DOSING OF MDM2 INHIBITOR
2021-01-07
20210000825
Tyrosine Kinase Non-Receptor 1 (TNK1) Inhibitors and Uses Thereof
2021-01-07
20210000826
PYRIMIDINE COMPOUNDS CONTAINING ACIDIC GROUPS AS TLR7 MODULATORS
2021-01-07
20210000827
CERDULATINIB FOR TREATING HEMATOLOGICAL CANCERS
2021-01-07
20210000828
Pharmaceutical Composition and Preparation Method Therefor and Uses Thereof
2021-01-07
20210000829
PHARMACEUTICAL COMPOSITION FORMED BY COMBINING PYRIDOXAMINE COMPOUND AND THIAMINE COMPOUND
2021-01-07
20210000830
CANCER TREATMENT METHOD USING Trk INHIBITOR AND KINASE INHIBITOR IN COMBINATION
2021-01-07
20210000831
AN AGENT FOR TREATING NOCTURNAL POLLAKIURIA
2021-01-07
20210000832
TOPICAL FORMULATION FOR A JAK INHIBITOR
2021-01-07
20210000833
INHIBITION OF NSMASE FOR THE TREATMENT OF HUMAN IMMUNODEFICIENCY VIRUS INFECTION
2021-01-07
20210000834
TREATMENT OF FOCAL SEGMENTAL GLOMERULOSCLEROSIS WITH CCR2 ANTAGONISTS
2021-01-07
20210000835
PHARMACEUTICAL FORMULATION OF PALBOCICLIB AND A PREPARATION METHOD THEREOF
2021-01-07
20210000836
Methods and Compositions for Treating Thyroid-Related Medical Conditions with Reduced Folates
2021-01-07
20210000837
HETEROCYCLIC COMPOUNDS AND USES THEREOF
2021-01-07
20210000838
COMBINATION THERAPY
2021-01-07
20210000839
METHODS AND SYNERGIC COMPOSITIONS FOR TREATING VIRAL INFECTIONS
2021-01-07
20210000840
MEDICAMENT FOR TREATING COUGH
2021-01-07
20210000841
COMPOUNDS THAT MODULATE VON WILLEBRAND FACTOR LEVELS AND THEIR USE IN THE TREATMENT OF BLOOD DISORDERS
2021-01-07
20210000842
TETRACYCLINE MANAGEMENT OF EGFR INHIBITOR ASSOCIATED DERMATOSES
2021-01-07
20210000843
SELECTIVE HIGH-AFFINITY POLYDENTATE LIGANDS AND METHODS OF MAKING SUCH
2021-01-07
20210000844
OPHTHALMIC COMPOSITION COMPRISING DIQUAFOSOL AND CATIONIC POLYMER
2021-01-07
20210000845
METHODS OF TREATING CANCER IN PEDIATRIC PATIENTS
2021-01-07
20210000846
USE OF AGONISTS OF FORMYL PEPTIDE RECEPTOR 2 FOR TREATING DERMATOLOGICAL DISEASES
2021-01-07
20210000847
BORON CONTAINING SMALL MOLECULES AS ANTI-INFLAMMATORY AGENTS
2021-01-07
20210000848
SYNTHETIC COMPOSITION FOR MICROBIOTA MODULATION
2021-01-07
20210000849
SYNTHETIC COMPOSITION AND METHOD FOR MODULATING EMOTION AND MOOD DISORDERS
2021-01-07
20210000850
Compositions for the Treatment of Metastatic Cancer
2021-01-07
20210000852
POLYDATIN PACLITAXEL COMPOSITION, AND APPLICATION IN PREPARING MEDICAMENT FOR PREVENTING AND TREATING GASTRIC CANCER
2021-01-07
20210000853
PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF
2021-01-07
20210000854
COMBINATION FORMULATION OF TWO ANTIVIRAL COMPOUNDS
2021-01-07
20210000855
RETINOL-BINDING PROTEIN 3 (RBP3) AS A PROTECTIVE FACTOR IN NON-DIABETIC RETINAL DEGENERATION
2021-01-07
20210000856
IMMUNOMODULATORY SMALL HAIRPIN RNA MOLECULES
2021-01-07
20210000857
COMPOSITION REMEDY TO PREVENT SYMPTOMS RELATED TO EXCESSIVE ALCOHOL CONSUMPTION
2021-01-07
20210000858
STEM CELL-DERIVED EXOSOMES FOR THE TREATMENT OF CORNEAL SCARRING
2021-01-07
20210000859
COMPOSITIONS FOR THE TREATMENT OF DRY EYE
2021-01-07
20210000860
COMPOSITIONS FOR TREATING MEIBOMIAN GLAND DYSFUNCTION
2021-01-07
20210000861
N-Acylated Hyaluronic Acid for Hyperuricemia and Gouty Arthritis
2021-01-07
20210000862
TREATMENT OF POST-OPERATIVE JOINT PAIN WITH POLYSULFATED POLYSACCHARIDES
2021-01-07
20210000863
POLYHYDROXYALKANOATES FOR USE IN PREVENTION OF COLORECTAL CANCERS
2021-01-07
20210000864
A COMPOSITION FOR USE IN THE TREATMENT OF CONDITIONS CAUSED BY CALCIUM DEFICIENCY
2021-01-07
20210000865
CALCIUM HYDROXIDE NANOPARTICLES SYNTHESIZED WITH CAROB PULP EXTRACT
2021-01-07
20210000866
COLONOSCOPY - PREPARATION
2021-01-07
20210000867
NEW ROUTE AND ENGINEERING PROTOCOLS FOR ALZHEIMERS DISEASE PREVENTION, TREATMENT AND NEURONAL REBUILDING
2021-01-07
20210000868
ENGINEERED METAL NANOPARTICLES AND METHODS THEREOF
2021-01-07
20210000869
CD19 SPECIFIC CHIMERIC ANTIGEN RECEPTOR AND USES THEREOF
2021-01-07
20210000870
BISPECIFIC CHIMERIC ANTIGEN RECEPTORS AND THEIR APPLICATION IN THE TREATMENT OF TUMOR
2021-01-07
20210000871
METHOD FOR PRODUCING A CELL POPULATION INCLUDING NK CELLS
2021-01-07
20210000872
BIOMARKER PREDICTIVE OF TUMOUR INFILTRATING LYMPHOCYTE THERAPY AND USES THEREOF
2021-01-07
20210000873
TECHNIQUES FOR GENERATING CELL-BASED THERAPEUTICS USING RECOMBINANT T CELL RECEPTOR GENES
2021-01-07
20210000874
METHODS OF SELECTING T CELL LINE FOR ADOPTIVE CELLULAR THERAPY
2021-01-07
20210000875
IL-13 RECEPTOR ALPHA 2 (IL13RA2) CHIMERIC ANTIGEN RECEPTOR FOR TUMOR SPECIFIC T CELL IMMUNOTHERAPY
2021-01-07
20210000876
Prostate Cancer Specific Marrow Infiltrating Lymphocytes and Uses Thereof
2021-01-07
20210000877
Method For Upregulation Of Thioredoxin Expression In Stem Cells
2021-01-07
20210000878
Muscle Derived Cells for the Treatment of Gastro-Esophageal Pathologies and Methods of Making and Using the Same
2021-01-07
20210000879
METHODS AND COMPOSITIONS FOR MRNA-BASED MODULATION AND DETECTION OF CELL PHENOTYPES
2021-01-07
20210000880
METHODS OF USE OF ISLET CELLS
2021-01-07
20210000881
AMNIOTIC OR PLACENTAL PREPARATION AND DEVICE FOR OPHTHALMIC USE AS DRESSING TO ENHANCE HEALING
2021-01-07
20210000882
PRODUCTION AND USE OF EXTRACELLULAR VESICLES
2021-01-07
20210000883
Method and System for Reducing the Likelihood of Osteoporosis
2021-01-07
20210000884
PROTEINS DERIVED FROM STREPTOCOCCUS PYOGENES BACTERIA AND USE THEREOF
2021-01-07
20210000885
Method for Reducing the Likelihood of Developing Bladder or Colorectal Cancer in an Individual Human Being
2021-01-07
20210000886
METHOD OF PREPARING AN INDIVIDUAL PROBIOTIC COMPOSITION ACCORDING TO ANALYSIS OF THE MICROBIOME AND MEDICAL HISTORY FOR HUMAN OR VETERINARY USE
2021-01-07
20210000887
METHODS AND COMPOSITIONS FOR REDUCING VANCOMYCIN-RESISTANT ENTEROCOCCI INFECTION OR COLONIZATION
2021-01-07
20210000888
PROBIOTIC THERAPIES FOR AUTISM
2021-01-07
20210000889
METHODS FOR PROGNOSING AND TREATING METABOLIC DISEASES
2021-01-07
20210000890
COMPOSITIONS AND METHODS FOR DENTAL CARE
2021-01-07
20210000891
MANAGEMENT OF PATHOGENIC LAWSONIA
2021-01-07
20210000892
USE OF DIRECT- FED MICROBIALS IN PREVENTING AND/OR TREATING E. COLI-BASED INFECTIONS IN ANIMALS
2021-01-07
20210000893
LACTOBACILLUS PLANTARUM STRAIN TCI227 AND USES OF THE LACTOBACILLUS PLANTARUM STRAIN TCI227 FOR REGULATING EXPRESSION OF IL-1BETA GENE, TNF-ALPHA GENE, MMP1a GENE AND TIMP1 GENE, AND TREATING GOUT
2021-01-07
20210000894
Anti-Stress Composition
2021-01-07
20210000895
EXOSOME TARGETING OF CD4+ EXPRESSING CELLS
2021-01-07
20210000896
SEAWEED-BASED POWDER
2021-01-07
20210000897
Compositions and Methods for Treating the Eye
2021-01-07
20210000898
COMPOSITION HAVING ERYTHROPOIETIN-INDUCING ACTIVITY, AND METHOD FOR PRODUCING SAME
2021-01-07
20210000899
VETERINARY CANNABINOID AND MENTHOL COMPOSITIONS AND METHODS
2021-01-07
20210000900
COMPOSITON FOR PREVENTING OR TREATING OSTEOPOROSIS
2021-01-07
20210000901
METHOD FOR OBTAINING AN EXTRACT ENRICHED IN ROSMARINIC ACID FROM FRESH PLANT MATERIAL
2021-01-07
20210000902
Natural Preservatives and Antimicrobial Agents, Including Compositions Thereof
2021-01-07
20210000903
CALMING COMPOSITION
2021-01-07
20210000904
NOVEL USE OF MAYDIS STIGMA EXTRACT IN PROPHYLAXIS AND THERAPY OF SLEEP DISORDER
2021-01-07
20210000905
Crude Drug Composition For Preventing Or Treating Respiratory Diseases
2021-01-07
20210000906
MODULATION OF HSD17B13 EXPRESSION
2021-01-07
20210000907
MICRONEEDLE-MEDIATED DELIVERY OF TOLEROGENIC IMMUNOTHERAPEUTICS
2021-01-07
20210000908
HMGB1 ANTAGONIST TREATMENT OF SEVERE SEPSIS
2021-01-07
20210000909
PEPTIDE COMPOSITION FOR TREATING EXCITATORY NEUROTOXICITY RELATED INJURIES
2021-01-07
20210000910
TOPICAL COMPOSITIONS
2021-01-07